Table 2.

Outcomes in the warfarin and DOAC groups.

Variable	Warfarin group (n = 28)	DOAC group (n = 45)	Univariable p value
All-cause mortality at 1 year	7 (25%) Respiratory failure (in hospital mortality) (3) Hospice care with subsequent demise (2) Pneumonia (1) Pulmonary hemorrhage (1)	3 (6.6%) Respiratory failure (in hospital mortality) 2 Hospice care with subsequent demise (1)	0.027
Any disease exacerbation at one year	9 (32.1%)	7 (15.5%)	0.096
Any disease exacerbation requiring hospitalization in 1 year	9 (32.1%)	5 (11.1%)	0.026
Major bleeding episode at one-year follow-up	2 (7.1%)	1 (2.2%)	0.303
Major bleeding event at any time during follow-up	2 (7.1%)	4 (8.89%)	0.79
Anticoagulation failure	1 (3.6%)	1 (2.2%)	0.73